China-UC Davis Health System 

Stroke Symposium


Sponsored by: SAHNT Foundation

September 9, 2015
Location: Center for Health and Technology
Program Chair: Brian Dahlin, MD, Assistant Professor

Introduction of Stroke Center at UC Davis Medical Center
Brian Dahlin, MD, Assistant Professor

RNA markers in blood as a method to distinguish stroke subtypes and predict causes in strokes
Glen Jickling, M.D., FRCPC, Assistant Professor
Frank Sharp, M.D., Professor

Transplantation of reprogrammed progenitor cells after stroke to enhance functional recovery
Ben Waldau, M.D., Assistant Professor

Touring Center for Health and Technology
Tod Stoltz, MBA
Brian Dahlin, MD, 


Assistant Professor
Dr. Dahlin is clinically active in both diagnostic and interventional neuroradiology. His specific interests include the diagnosis and treatment of vascular, congenital, and neoplastic diseases of the head and neck. He specializes in endovascular and image-guided diagnostic and therapeutic procedures including acute stroke intervention, intracranial aneurysm and AVM embolization, pre-operative embolization of vascular tumors, and sclerotherapy of vascular and lymphatic malformations of the head and neck.

Glen Jickling, M.D., FRCPC
Assistant Professor

Dr. Glen Jickling has a strong interest in vascular neurology, including ischemic stroke and hemorrhagic stroke. His research focuses on the role of the immune system in cerebrovascular disease including patterns of gene expression and epigenetic regulation. He has described RNA markers in blood as a method to distinguish stroke subtypes and predict cause in strokes of unclear etiology. Dr. Jickling is on the editorial boards of several journals, and receives research funding from the American Heart Association and the National Institutes of Health.

Frank Sharp, M.D.
Professor

Dr. Frank Sharp is conducting research using both human patients and animal models of stroke to understand the subtleties of these deadly incidents. He is seeking ways to improve surgical techniques for repairing brain damage following stroke, studying the ability of heat shock proteins (produced by cells under stress) to protect brain tissue from injury due to stroke, and also investigating new drug therapies for stroke.

Ben Waldau, M.D.

Assistant Professor
Dr. Ben Waldau is interest in stroke and extracranial carotid disease which he can treat with carotid endarterectomy or carotid angioplasty and stenting. His research focuses on transplantation of reprogrammed progenitor cells after stroke to enhance functional recovery. Human subventricular progenitor cells are harvested and reprogrammed to become motor neurons in collaboration with the UC Davis Stem Cell Program. The overall goal is to gather sufficient data to start clinical trials in stroke patients in the future.